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http://dx.doi.org/10.1016/j.asjsur.20Summary Background/Objective: Maggot wound therapy (MWT) has been used in various
wounds including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and acute surgical
wounds. However, the efficacy of MWT therapy has been controversial. We therefore conduct-
ed a cohort study and a meta-analysis to assess MWT effects.
Methods: A retrospective cohort study was performed in diabetic foot ulcer (DFU) patients who
were treated with MWT or conventional wound therapy (CWT) in Thailand. The Kaplan-Meier
curve was applied to estimate the healing probability. A meta-analysis was performed to pool
our study with four previous cohort studies identified from Medline and Scopus.
Results: The estimated incidence of wound healing was 5.7/100 (95% CI: 4.49, 7.32) patients-
week, and the median time to healing was 14 weeks. The hazard ratio (HR) of wound healing
was 7.87 times significantly higher in the MWT than the CWT (p < 0.001) after adjusting for
duration and size of ulcers, ankle brachial index (ABI), and glycated hemoglobin (HbA1c).
Meta-analysis was applied and suggested that the treatment effects were moderately hetero-
geneous {Chi-squareZ 6.18 [degrees of freedom (d.f.)Z 4]; pZ 0.186; I2Z 35.2%}, with the
pooled risk ratio (RR) of 1.77 [95% confidence intervals (CI) Z 1.01, 3.11], i.e., the chance of
wound healing was 20% significantly higher with MWT than CWT. The average costs ofeclare that they have no financial or non-financial conflicts of interest related to the subject matter
ipt.
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Maggot therapy for chronic ulcer 139treatment in patients with DFU were lower in the MWT group than in the CWT group, with me-
dians of US$292.82 and US$490, respectively.
Conclusion: Our evidence suggests that MWT is significantly better for wound healing and more
cost-effective than CWT. An updated meta-analysis or large scale randomized controlled trial
(RCT) is required to confirm this effect.
Copyright ª 2013, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Background
One of the important aspects of wound management,
especially in intractable wounds, is removal of necrotic
tissue, which is known as debridement. The use of maggots
for this purpose has been claimed to be an efficacious
method,1,2 that stimulates wound healing,3,4 reduces the
bacterial load,5 and eradicates methicillin resistant
Staphylococcus aureus in vitro.6,7 Maggot wound therapy
(MWT) has been applied in various settings, e.g., diabetic
foot ulcers (DFU),8,9 peripheral arterial diseases,10 venous
leg ulcers,11 pressure ulcers,12 and acute surgical
wounds.13,14
The use of MWT is increasing as a reflection of the
increasing acceptance since approval by the Food and Drug
Administration. The recent enthusiasm for MWT is sup-
ported and calls for public attention. However, the results
of MWT treatment are still controversial.10 A randomized
controlled trial (RCT)15 could not demonstrate differences
in the rate of wound healing and healing time between
MWT and standard treatment in venous leg ulcers, although
MWT did reduce the time to debridement by approximately
2 days, but with significantly higher pain scores. The cost-
effectiveness of MWT has been reported in some studies
with conflicting results3e5; MWT was initially shown to have
lower costs of treatment and require fewer visits, but these
could not be confirmed in a recent RCT study.16
We, therefore, performed a retrospective cohort study
and follow-up meta-analysis of comparative studies to
evaluate wound healing outcomes with MWT compared with
conventional wound therapy (CWT).2. Materials and methods2.1. Cohort study
A retrospective cohort study was performed by reviewing
the medical records of diabetic DFU patients who were
treated at Bang Yai Hospital, Nonthaburi Province, Thailand
from January 2008 to December 2009. Bang Yai hospital is a
30-bed hospital that provides primary care services. Pa-
tients who met the following criteria were included in the
study: (1) presence of a single wound of the foot; (2) ability
to walk without the use of a wheelchair or other assistive
device; (3) data were available for at least 6 months of
follow-up; and (4) no gangrenous wounds, necrotizing fas-
ciitis, abscess, or osteomyelitis present. Patients were
assigned by physicians who were well trained in chronicwound care, to receive MWT or CWT at the out-patient
clinic or in-patient wards, based on physician judgment.
Maggots were prepared by Biomonde Thailand Co. Ltd.,
Bangkok, Thailand using a standard biological room. Briefly,
adult flies were kept in a temperature-controlled room
(25 C) with constant light, air, and humidity (33%). After
oviposition was documented, the eggs were transferred to a
clean room and they were fed with sheep blood agar until
they reached the post-feeding stage.17,18 Then, maggots
were applied to the wounds in a bio-bag, with an average of
eight maggots/cm2 of wound surface.19 The wound was
covered with wet light gauze, and the entire foot was
loosely bandaged. The median number of applications of
maggots was 8.25 [standard deviation (SD)Z 5e13] times/
patient. For the control group, the wound was dressed with
normal saline or hydrogel and debridement was performed
as judged by the treating physician. The wounds were
debrided with a median of 8.79 (SDZ 5e14) times/patient.
The wound was evaluated once/week by nurse practi-
tioners and evaluated using digital photographic images.
Patients were classified as having wound healing if their
wounds had  95% complete epithelial covering in the
absence of a scab, and the wounds were suitable for split
skin grafting, flap coverage, or self-healing.20 Healing time
was defined as the time from treatment initiation to wound
healing. Patients were followed up from treatment initia-
tion until the end of December 2009. The study was
approved by the Institutional Review Board prior to con-
ducting the study and all participants had given informed
consent.3. Meta-analysis
Studies were identified using PubMed and Scopus search
engines from January 1946 to September 15, 2011. The
search strategy is described in Appendix 1.3.1. Inclusion criteria
Comparative studies of MWT and CWT were included in the
review if they met with the following criteria: patients aged
 18 years and compared wound healing rate or wound
healing time between groups. The reference lists of all
relevant studies were also reviewed. If studies were
duplicated, the one with the most complete data was
chosen. For studies which reported insufficient data, the
corresponding authors were contacted and invited to pro-
vide more information. Two attempts were made to contact
140 C. Wilasrusmee et al.authors and those who did not respond were excluded from
the review.
3.2. Outcomes
The outcomes of interest were the rate of wound healing
and/or healing time.
3.3. Data extraction
Two investigators (CW and NP) independently extracted the
data using a standard data extraction form. Information
extracted included general data (author, year of publica-
tion, journal), study characteristics (study design, setting),
patient characteristics at baseline (age, type of wound,
underlying disease, white blood cell count, ABI, percent
amputation), and the outcomes as described above. Any
disagreement was discussed and resolved by consensus with
a third party (AT).
3.4. Risk of bias assessment
The quality of the cohort studies was independently
assessed by CW, NP, and AT on the basis of representa-
tiveness of studied participants, information bias (i.e.,
ascertainment of outcome and treatment), and confound-
ing bias (Appendix 2). For the RCT study, the assessment
was done using established tools recommended by the
Cochrane Library.21 Each item was graded as “no” for risk of
bias, “yes” for risk of bias, and “unclear” if there was
insufficient information to judge. Any disagreement be-
tween the reviewers was discussed and resolved by
consensus.21
3.5. Statistical analysis
For the cohort study, the Kaplan-Meier method was applied
to estimate the healing probability at 7 weeks, 14 weeks,
21 weeks, and 28 weeks after receiving treatments. The
median healing times and 95% confidence intervals (CI)
were estimated. The log-rank test was used to compare the
time to healing between treatments and prognostic factors.
Factors with p < 0.1 were included in the multivariate
Cox regression model. The likelihood ratio test with for-
ward elimination was used to select variables in the Cox
model. Hazard ratios (HR) and 95% CI were estimated.
For meta-analysis, the risk ratio (RR) of wound healing
for each included study was estimated. The heterogeneity
of RRs across studies was assessed using Cochran’s Q test
and the degree of heterogeneity was quantified using the I2
statistic. If the heterogeneity was significant or I2 > 25%, a
random effects model using the Der-Simonian and Laird
method was applied for pooling ORs, otherwise the fixed
effects model was used.
For healing time, the mean difference of healing time of
each study was estimated. The heterogeneity of the mean
difference across studies was assessed as described above.
An unstandardized mean difference was used for the sum-
mary estimate.
Meta-regression analysis was used to assess the source of
heterogeneity by fitting age and type of wound in the meta-regression model. Funnel plot with or without contour-
enhancement was applied to detect publication bias due to
small study effects. Egger’s test was used for assessing the
asymmetry of the funnel plot.
All analyses were performed using STATA version 12.0
(StataCorp LP, College Station, TX). A p value < 0.05 was
considered statistically significant, except for the hetero-
geneity test, for which p < 0.1 was used.4. Results4.1. Cohort study of diabetic wound healing
One hundred and eleven diabetic patients, with 1116
person-weeks of follow-up, were included in the cohort.
Among them, 59 patients and 52 patients received MWT and
CWT, respectively. Characteristics at baseline are
described in Table 1. The mean ages were similar between
two groups, i.e., 55.6 (SD Z 12.20) years and 53.4
(SD Z 11.42) years, respectively. Glycated hemoglobin
(HbA1c) levels at baseline were also similar between
groups, i.e., 7.0 (SD Z 1.40) and 7.1 (SD Z 1.87), respec-
tively. However, the proportion with an abnormal ABI
(< 0.9 or > 1.1) was much lower in the MWT group than in
the CWT group (30.0% vs. 67.3%). In addition, patients in
the MWT group had a smaller size (26.1 cm2 vs. 32.1 cm2)
and a shorter duration (18.1 vs. 23.5) of ulcers than pa-
tients in the CWT group. The median number of applica-
tions of maggots was 8.25 (SD Z 5e13) times/patient.
Among the cohort of 111 patients, there were 64 whose
wounds were healed at the end of the study, with a me-
dian follow-up of 14 weeks (range Z 0e45 weeks). The
estimated incidence of wound healing was 5.7/100
patients-week, and the median time to healing was 14
weeks (95% CI: 10, 15), i.e., there were 50% of patients
whose wounds were healed at approximately 14 weeks.
The probability of healing at 7 weeks, 14 weeks, 21 weeks,
and 28 weeks was 25.85% (95% CI: 19, 35), 56.24% (95% CI:
46, 67), 72.84% (95% CI: 62, 83), and 90.95% (95% CI: 70,
99), respectively.
The probability of healing between treatment groups
was estimated and the log-rank test was applied to
compare the medians by treatment and prognostic vari-
ables (Table 2). As shown in Fig. 1, the median healing time
was significantly shorter in the MWT group than in the CWT
group (9 weeks vs. 28 weeks, Chi-square Z 55.82,
p < 0.001). In addition, ABI, duration of ulcer, and size of
ulcer were significantly associated with wound healing. The
median time to healing was shorter in patients whose
duration of ulcer was < 20 days when compared with pa-
tients whose durations were  20 days (8 weeks vs. 15
weeks, Chi-square Z 49.02, p < 0.001). Patients whose
areas of ulcer were smaller than 28 cm2 took approximately
9 weeks to reach wound healing, whereas patients whose
areas were 28 cm2 or larger took 15 weeks (Chi-
square Z 23.66, p < 0.001). The median healing time was
significantly longer in patients with abnormal ABI than in
those with normal ankle brachial index (15 weeks vs. 10
weeks, Chi-square Z 6.73, p Z 0.01).These significant
variables were further included in the multivariate Cox
Table 1 Demographic characteristics of 111 patients with diabetic foot ulcers.
Parameters MWT CWT p
Number 59 52
Age (y) 55.5  12.2 53.4  11.4 0.4
Male:Female (%) 31:28 (1.1:1) 30:22 (1.4:1) 0.6
HbA1c 7.0  1.4 7.1  1.9 0.9
ABI
< 0.40 6 (8.6) 10 (7.4) 0.47
0.50e0.89 15 (14.5) 12 (12.5)
0.90e1.29 35 (32.1) 25 (27.9)
> 1.30 4 (4.8) 5 (4.2)
Underlying disease
Hypertension 30 (30.5) 27 (26.5) 0.84
Coronary arterial disease 24 (24.1) 21 (20.9) 0.97
Chronic renal failure 6 (5.4) 4 (4.6) 0.67
Size of ulcer (cm2) 26.1  12.8 32.1  10.9 0.005
Duration of ulcer (d) 18.1  4.9 23.5  8.2 < 0.001
Wound closure
Self-healing 44 (45) 40 (39) 0.89
Skin graft 10 (9.6) 8 (8.4)
Flap coverage 6 (5.4) 4 (4.6)
Hospital cost, Baht, median (range) 8784.7 (728.5, 8784.6) 14,700 (1062.9, 14928) < 0.001
Data are presented as n (%) or mean  SD unless otherwise indicated.
CWT Z conventional wound therapy; MWT Z maggot wound therapy.
Table 2 Factors associated with wound healing.
Factors No. of
healing
Person
time (wk)
Healing
rate/100
Median healing
time (wk)
Univariate Multivariate
Hazard ratio p Hazard ratio p 95% CI
Treatment
Maggot 51 682 11.75 9 7.66 < 0.001 7.72 < 0.001 3.83, 15.56
Conventional 13 434 1.91 28 1 1
Duration of wound (d)
< 20 38 349 10.89 8 7.93 < 0.001 8.17 < 0.001 3.43, 19.46
 20 26 746 3.48 15
Size of wound (cm2)
< 28 44 468 9.40 9 3.20 < 0.001 2.09 0.027 1.09, 4.00
 28 20 648 3.09 15
HbA1c
 7 34 622 3.20 14 1.34 0.20 1.02 0.91 0.61, 1.73
> 7 30 454 3.29 14 1 1
ABI
< 0.9 or > 1.3 23 577 3.99 15 0.54 0.01 1.03 0.92 0.59, 1.81
0.9e1.3 41 539 7.60 10 1 1
Age (y)
 55 38 656 3.60 14 0.98 0.92
> 55 26 460 3.06 12 1
Sex
Female 28 623 3.66 12 0.90 0.66
Male 37 493 2.50 14 1
ABI Z Ankle brachial index; CI Z confidence interval; HbA1c Z glycated hemoglobin.
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Figure 1 Kaplan-Meier estimates of healing between maggot wound therapy (MWT) and conventional wound therapy (CWT).
142 C. Wilasrusmee et al.model. There were non-significant differences according to
age, sex, and HbA1c.
The treatment effect was further estimated in the Cox
model by adjusting for ankle brachial index, HbA1c, size
of ulcer, and duration of ulcer (Table 2). This suggested
that after adjusting for ABI, HbA1c, size of ulcer, and
duration of ulcer, the chance of wound healing was
approximately 7.7 (95% CI: 3.83, 15.56) times significantly
higher in the MWT group than the CWT group.
In addition, duration and size of wound were signifi-
cantly associated with wound healing, with HR of 8.17 (95%
CI: 3.43, 19.46) and 2.09 (95% CI: 1.09, 4.00), respectively.
The ABI was no longer significant in this model. A global Chi-
square test based on Schoenfeld residuals was performed
and suggested that the Cox proportional hazards assump-
tion was not violated [Chi-square Z 5.57, degrees of
freedom (d.f.) Z 5, p Z 0.3498].Figure 2 Identification of studies for inclusion.4.2. Meta-analysis
Among 272 studies identified from Medline and Scopus da-
tabases, 267 studies were ineligible, leaving five studies
which were eligible to pool (Fig. 2). Characteristics of the
six studies, including ours(Wilasrusmee et al,
unpublished)16,20,22e24 are described in Table 3; a total of
612 patients (345 vs. 267) were available for analysis.
Among five studies, two were prospective cohort
studies,20,24 two were retrospective cohorts,22,23 and one
was a multicenter RCT.16 Three studies were based in the
United States, one in the United Kingdom, and one in
Malaysia. The mean patient age ranged from 54.6 years to
74.0 years. The types of wound were diabetic ulcers (4
studies; Wilasrusmee et al, unpublished),20,22,24 venous ul-
cers (1 study),16 and pressure ulcers (1 study).234.3. Risk of bias assessment
Among six studies, (Wilasrusmee et al,
unpublished)16,20,22e24 the risk of selection bias from the
use of non-representative cases was present in four (80%)
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Maggot therapy for chronic ulcer 143studies. The ascertainment of all outcomes was clearly
described in three out of five (60%) studies,20,22,23 whereas
the other two (40%) studies were unclear. The ascertain-
ment of intervention was clear in five (80%) studies. Unclear
ascertainment was found in one study, due to switching
between CWT and MWT. Confounding bias was found likely
to be present in three (60%) studies. In the RCT study,15 the
quality was high except in the domain of blinding.
4.4. Rate of wound healing
Pooling was performed based on four cohort studies20,22e24
plus ours (Wilasrusmee et al, unpublished; nZ 171 vs. 174).
The RR was highly heterogeneous [Chi-square Z 16.64
(d.f.Z 4); pZ 0.002; I2Z 76.04%) across the studies. The
pooled RR with a random effect model was 1.77 (95% CI:
1.01, 3.11), suggesting that the chance of wound healing
was 77% higher in the MWT group compared to the CWT
group (Fig. 3A). Neither Egger’s test nor the funnel plot
suggested asymmetry (coefficient Z 0.57, SE Z 3.66,
p Z 0.89; see Fig. 3B).
A sensitivity analysis was performed by adding the
RCT176 to the pooling (n Z 612) which resulted in
the pooled RR of 1.53 (95% CI: 1.23, 1.90), indicating that
the chance of wound healing was 53% significantly higher
in the MWT group compared to the CWT group. Subgroup
analyses of four diabetic studies and three studies with
good ascertainment of outcome resulted in the pooled RR
of 1.74 (95% CI: 0.85, 3.53) and 1.40 (95% CI: 1.23, 1.58),
respectively.
4.5. Healing time
Four studies (Wilasrusmee et al, unpublished)22e24 (nZ 146
vs. 145) were included in pooling of the healing time. The
pooled effectwas highly heterogeneous [Chi-squareZ 14.05
(d.f. Z 3); p Z 0.003; I2 Z 78.6%] across studies with an
unstandardized mean difference of e15.99 (95% CI: e38.95,
6.97) days (Fig. 3C). This suggested that the healing timewas
15.99 days shorter in theMWT group than the CWT group, but
this was not statistically significant. Neither Egger’s test nor
a funnel plot suggested asymmetry (coefficient Z e0.42,
SEZ 3.71, pZ 0.92; see Fig. 3D).
Adding the RCT study16 (n Z 585) did not change the
results, with an unstandardized mean difference of e14.56
(95% CI: e32.91, 3.80) days.
4.6. Cost-effectiveness analysis
Among 111 patients, the total direct medical cost of
treatments was estimated for each patient, including the
costs for nursing care, admission, wound dressing, and
material used for treatments.
The average cost of treatments was lower in the MWT
group than the CWT group, with a median of 8784.66 baht
(range Z 728.59, 8784.66) and 14,700 baht
(range Z 1062.95, 14928.00; p < 0.001), which is approxi-
mately equivalent to US$292.82 andUS$490, respectively. As
described in Table 2, themedian healing times were 9 weeks
and 28 weeks for the MWTand the CWT groups, respectively.
The corresponding healing rates were 12/100 patients-week
Figure 3 Meta-analysis of rate of wound healing and healing time between maggot wound therapy (MWT) and conventional
wound therapy (CWT).
144 C. Wilasrusmee et al.and 2/100 patients-week, respectively. As a result, the
incremental cost-effectiveness ratios were e311.3
ande591.53 for healing time and healing rate, respectively.5. Discussion
We performed a cohort study and a meta-analysis to
investigate the effect of MWT compared with CWT. Our
findings from the cohort study suggest that MWT has w7
times higher chance of wound healing than CWT. The time
to healing was also w19 weeks shorter in the MWT group
than in the CWT group. In addition, the duration and size of
wounds were also associated with wound healing. The MWT
effects were, however, diluted and highly heterogeneous
when we combined our findings with other cohort studies,
with a pooled RR of 1.77 and time to healing of 2 weeks.
The incremental cost-effectiveness ratios for healing rate
and healing time were 591.5 baht (US$ w20) and 311.3
baht (US$ w10) lower in the MWT group than in the CWT
group.
Various new technologies, pharmaceuticals, and de-
vices have been proposed in an effort to promote wound
healing.25 It is difficult to make strong recommendations
in wound management, due to a paucity of high quality
evidence, inadequate sample size, limited follow-up
period, non-random allocation of treatment and control,
concurrent intervention, and blinding assessment of
outcomes.26The wound healing properties of MWT have been
demonstrated in many studies.27e29 In addition to directly
ingesting necrotic tissue, maggots appear to indirectly
promote healing by inducing and amplifying interleukin-6,
carboxypeptidase, leucine aminopeptidase, collagenase,
serine proteases, and epidermal growth factor.27,30 They
also stimulated the proliferation of human fibroblasts and
chondrocytes, as well as the synthesis of cartilage-specific
collagen type II and allantoin, which has a soothing effect
on the skin.29 The United States Food and Drug Adminis-
tration (FDA) approved MWT for the debridement of non-
healing necrotic skin and soft tissue wounds, such as pres-
sure ulcers, venous stasis ulcers, neuropathic foot wounds,
and postoperative wounds.27
The cost of management for MWT in our patients was
less than that for CWT, due mainly to a more rapid decrease
in wound size, an increase in granulation tissue, and better
wound preparation for surgical closure.31,32 Laboratory
evidence strongly supports the beneficial effects of MWT in
removing pathogenic bacteria both in vitro and in vivo.5e33
MWT has been reported as a cost-effective method in
debridement and treatment of DFU,2 venous ulcer,34 and
various difficult-to-treat wounds.31 However, economic
evaluation in the single RCT16 demonstrated small or similar
health benefits of MWT over CWT (hydrogel), as measured
by quality adjusted life years (QALY) and time to healing.
The cost effectiveness analysis in our study has shown that
MWT is a cost saving method when compared to CWT.
However, our study analysis was based on the retrospective
Maggot therapy for chronic ulcer 145cohort study of patients in Thailand, which has different
cost structures than Western countries. It should also be
kept in mind that patients with less severe ulcers were
more likely to assign to MWT than CWT. As a result, cost
analysis might be bias.
Although the ABI was not significantly associated with
wound healing in the multivariate Cox model, time to
healing between ABI groups were different; i.e., 14 weeks,
14 weeks, 11 weeks, and 12 weeks for ABI  0.4, 0.5e0.9,
0.9e1.3, and > 1.3,35 respectively. Because our sample size
was small, ABI of  0.4, 0.5e0.9, and > 1.3 were thus
combined as abnormal groups when fitting in the Cox model
in order to prevent the model from over fitting.
The benefits of MWT of improved wound healing were
confirmed in our cohort study, which demonstrated a better
wound healing rate and shorter time to healing. Our meta-
analysis, the first in this area, showed that MWTwas at least
as effective as CWT, if not better; the 95% CI was borderline
significant (1.01, 3.11) with a heterogeneous RR of 1.77
from five comparative studies and 345 patients. The only
RCT study16 in 267 patients indicated a slightly increased
likelihood of healing, but did not find any significant dif-
ferences; the HR was 1.13 (95% CI: 0.76, 1.68). The wound
healing time was 16 days shorter in the meta-analysis of
four studies with 393 patients, but this did not reach sta-
tistical significance, whereas it was 9 days non-significantly
shorter than reported in the RCT.16 Important limitations
include the fact that our retrospective cohort and the
included studies were mainly observational studies, which
were more likely to face selection and confounding biases;
thus cause and effect relationships cannot be inferred from
our main finding. There was high heterogeneity in the
pooled estimates; generalization of maggot effects was less
likely. Performing a subgroup analysis in DFU patients could
not reduce a degree of heterogeneity and resulted in non-
significant maggot effects, due to the power of the test.
However, the RCT study results were largely similar, but
suffered from poor precision. More RCT studies are needed
to better define this potential benefit.
The results of this study should help physicians decide on
the choice of appropriate interventions for their patients.
Our evidence suggests that MWT is significantly better in
wound healing than CWT, and at less cost. This, however,
needs to be confirmed by a large scale RCT or a meta-
analysis of RCTs.Financial disclosures
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3 Diabetes
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6 Diabetic foot wound
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17 Maggot debridement
18 Maggot healing
19 Maggot therapy
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25 Hydrogel
26 Wet dressing
27 Wound care
28 Wound therapy
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36 Wound infection
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